Industry Research Reports
Home > Reports > Service & Software > Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Service & Software
Published Date: 2026-01-14
Pages: 98 Pages
Report ld: 5649941
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Lung Cancer Screening Software Market Size(US$)
CAGR 2026-2032
18.0%
Market Size,2032
USD 5,434
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,013 million
Market Forecast in 2032(Value)
US$ 5,434 million
CAGR
18.0%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lung Cancer Screening Software market size was US$ 1706 million in 2025 and is forecast to reach a readjusted size of US$ 5434 million by 2032 with a CAGR of 18.0% during the forecast period 2026-2032.
Lung cancer screening software is medical software based on medical imaging (primarily low-dose CT) and algorithm models. It is used to automatically detect lung nodules, analyze morphological characteristics, assess malignancy risk, and assist in follow-up management. Its goal is to improve the early detection rate of lung cancer, reduce the missed diagnosis rate, and support clinical decision-making and population screening.
Upstream components mainly include medical imaging data sources (CT equipment, imaging centers), computing power and cloud infrastructure, algorithm frameworks, and data annotation resources. Downstream components primarily target hospital radiology departments, regional public health screening projects, physical examination institutions, and health management and insurance-related service scenarios.
Global Market Future Development Trends
With the increasing incidence of lung cancer and the aging population, low-dose CT screening is being included in recommended or pilot programs in more and more countries. Traditional manual image interpretation is insufficient to support large-scale screening, making efficient and replicable software solutions a necessity and driving the rapid deployment of lung cancer screening software in hospitals and regional population screening.
The market is evolving from single nodule detection to risk stratification, follow-up comparison, multi-temporal analysis, and automated reporting. Algorithm stability, cross-device generalization ability, and clinical interpretability have become core competitive advantages, elevating the value of software from an "auxiliary tool" to a "key node in the screening process."
Against increasingly stringent regulatory requirements from the FDA, CE, and NMPA, compliance certification has become a market entry barrier. In the future, software will increasingly take the form of platforms, integrating with PACS, regional screening systems, and cloud services, transforming from single-point sales to long-term service revenue through subscription or pay-per-view models.
The global Lung Cancer Screening Software market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems
- United Imaging Healthcare
- InferVision
- Airdoc
- VUNO
- Lunit
- Qure.ai
- Riverain Technologies
- Zebra Medical Vision
- Arterys
- Deepwise
- EverFortune AI
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cloud-Based
- Web-Based
Segment by Application
- Hospitals
- Medical Examination Institutions
- Public Health Screening
- Others
Segment by Category
- Nodule Detection
- Nodule Analysis
- Full-Process Screening
- Predictive Assessment
Segment by Division
- Standalone AI Software
- PACS/RIS Integrated Plugin
- Built-in Solution for Imaging Equipment
- Regional Screening Platform System
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Lung Cancer Screening Software value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Cloud-Based
1.2.3 Web-Based
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Medical Examination Institutions
1.3.4 Public Health Screening
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Screening Software Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Lung Cancer Screening Software Market Share by Revenue, by Region (2021-2026)
2.4 Global Lung Cancer Screening Software Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Lung Cancer Screening Software Market Size and Prospective (2021-2032)
2.5.2 Europe Lung Cancer Screening Software Market Size and Prospective (2021-2032)
2.5.3 China Lung Cancer Screening Software Market Size and Prospective (2021-2032)
2.5.4 Japan Lung Cancer Screening Software Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Lung Cancer Screening Software Historical Market Size by Type (2021-2026)
3.2 Global Lung Cancer Screening Software Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Lung Cancer Screening Software
4 Breakdown Data by Application
4.1 Global Lung Cancer Screening Software Historical Market Size by Application (2021-2026)
4.2 Global Lung Cancer Screening Software Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Lung Cancer Screening Software Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Lung Cancer Screening Software Players by Revenue (2021-2026)
5.1.2 Global Lung Cancer Screening Software Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Lung Cancer Screening Software Revenue
5.4 Global Lung Cancer Screening Software Market Concentration Analysis
5.4.1 Global Lung Cancer Screening Software Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Screening Software Revenue in 2025
5.5 Global Key Players of Lung Cancer Screening Software Head Offices and Areas Served
5.6 Global Key Players of Lung Cancer Screening Software, Product and Application
5.7 Global Key Players of Lung Cancer Screening Software, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Lung Cancer Screening Software Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Lung Cancer Screening Software Market Size by Type (2021-2026)
6.1.2.2 North America Lung Cancer Screening Software Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Lung Cancer Screening Software Market Size by Application (2021-2026)
6.1.3.2 North America Lung Cancer Screening Software Market Share by Application (2021-2026)
6.1.4 North America Lung Cancer Screening Software Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Lung Cancer Screening Software Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Lung Cancer Screening Software Market Size by Type (2021-2026)
6.2.2.2 Europe Lung Cancer Screening Software Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Lung Cancer Screening Software Market Size by Application (2021-2026)
6.2.3.2 Europe Lung Cancer Screening Software Market Share by Application (2021-2026)
6.2.4 Europe Lung Cancer Screening Software Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Lung Cancer Screening Software Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Lung Cancer Screening Software Market Size by Type (2021-2026)
6.3.2.2 China Lung Cancer Screening Software Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Lung Cancer Screening Software Market Size by Application (2021-2026)
6.3.3.2 China Lung Cancer Screening Software Market Share by Application (2021-2026)
6.3.4 China Lung Cancer Screening Software Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Lung Cancer Screening Software Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Lung Cancer Screening Software Market Size by Type (2021-2026)
6.4.2.2 Japan Lung Cancer Screening Software Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Lung Cancer Screening Software Market Size by Application (2021-2026)
6.4.3.2 Japan Lung Cancer Screening Software Market Share by Application (2021-2026)
6.4.4 Japan Lung Cancer Screening Software Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Key Player Profiles
7.1 Siemens Healthineers
7.1.1 Siemens Healthineers Company Details
7.1.2 Siemens Healthineers Business Overview
7.1.3 Siemens Healthineers Lung Cancer Screening Software Introduction
7.1.4 Siemens Healthineers Revenue in Lung Cancer Screening Software Business (2021-2026)
7.1.5 Siemens Healthineers Recent Development
7.2 GE HealthCare
7.2.1 GE HealthCare Company Details
7.2.2 GE HealthCare Business Overview
7.2.3 GE HealthCare Lung Cancer Screening Software Introduction
7.2.4 GE HealthCare Revenue in Lung Cancer Screening Software Business (2021-2026)
7.2.5 GE HealthCare Recent Development
7.3 Philips Healthcare
7.3.1 Philips Healthcare Company Details
7.3.2 Philips Healthcare Business Overview
7.3.3 Philips Healthcare Lung Cancer Screening Software Introduction
7.3.4 Philips Healthcare Revenue in Lung Cancer Screening Software Business (2021-2026)
7.3.5 Philips Healthcare Recent Development
7.4 Canon Medical Systems
7.4.1 Canon Medical Systems Company Details
7.4.2 Canon Medical Systems Business Overview
7.4.3 Canon Medical Systems Lung Cancer Screening Software Introduction
7.4.4 Canon Medical Systems Revenue in Lung Cancer Screening Software Business (2021-2026)
7.4.5 Canon Medical Systems Recent Development
7.5 United Imaging Healthcare
7.5.1 United Imaging Healthcare Company Details
7.5.2 United Imaging Healthcare Business Overview
7.5.3 United Imaging Healthcare Lung Cancer Screening Software Introduction
7.5.4 United Imaging Healthcare Revenue in Lung Cancer Screening Software Business (2021-2026)
7.5.5 United Imaging Healthcare Recent Development
7.6 InferVision
7.6.1 InferVision Company Details
7.6.2 InferVision Business Overview
7.6.3 InferVision Lung Cancer Screening Software Introduction
7.6.4 InferVision Revenue in Lung Cancer Screening Software Business (2021-2026)
7.6.5 InferVision Recent Development
7.7 Airdoc
7.7.1 Airdoc Company Details
7.7.2 Airdoc Business Overview
7.7.3 Airdoc Lung Cancer Screening Software Introduction
7.7.4 Airdoc Revenue in Lung Cancer Screening Software Business (2021-2026)
7.7.5 Airdoc Recent Development
7.8 VUNO
7.8.1 VUNO Company Details
7.8.2 VUNO Business Overview
7.8.3 VUNO Lung Cancer Screening Software Introduction
7.8.4 VUNO Revenue in Lung Cancer Screening Software Business (2021-2026)
7.8.5 VUNO Recent Development
7.9 Lunit
7.9.1 Lunit Company Details
7.9.2 Lunit Business Overview
7.9.3 Lunit Lung Cancer Screening Software Introduction
7.9.4 Lunit Revenue in Lung Cancer Screening Software Business (2021-2026)
7.9.5 Lunit Recent Development
7.10 Qure.ai
7.10.1 Qure.ai Company Details
7.10.2 Qure.ai Business Overview
7.10.3 Qure.ai Lung Cancer Screening Software Introduction
7.10.4 Qure.ai Revenue in Lung Cancer Screening Software Business (2021-2026)
7.10.5 Qure.ai Recent Development
7.11 Riverain Technologies
7.11.1 Riverain Technologies Company Details
7.11.2 Riverain Technologies Business Overview
7.11.3 Riverain Technologies Lung Cancer Screening Software Introduction
7.11.4 Riverain Technologies Revenue in Lung Cancer Screening Software Business (2021-2026)
7.11.5 Riverain Technologies Recent Development
7.12 Zebra Medical Vision
7.12.1 Zebra Medical Vision Company Details
7.12.2 Zebra Medical Vision Business Overview
7.12.3 Zebra Medical Vision Lung Cancer Screening Software Introduction
7.12.4 Zebra Medical Vision Revenue in Lung Cancer Screening Software Business (2021-2026)
7.12.5 Zebra Medical Vision Recent Development
7.13 Arterys
7.13.1 Arterys Company Details
7.13.2 Arterys Business Overview
7.13.3 Arterys Lung Cancer Screening Software Introduction
7.13.4 Arterys Revenue in Lung Cancer Screening Software Business (2021-2026)
7.13.5 Arterys Recent Development
7.14 Deepwise
7.14.1 Deepwise Company Details
7.14.2 Deepwise Business Overview
7.14.3 Deepwise Lung Cancer Screening Software Introduction
7.14.4 Deepwise Revenue in Lung Cancer Screening Software Business (2021-2026)
7.14.5 Deepwise Recent Development
7.15 EverFortune AI
7.15.1 EverFortune AI Company Details
7.15.2 EverFortune AI Business Overview
7.15.3 EverFortune AI Lung Cancer Screening Software Introduction
7.15.4 EverFortune AI Revenue in Lung Cancer Screening Software Business (2021-2026)
7.15.5 EverFortune AI Recent Development
8 Lung Cancer Screening Software Market Dynamics
8.1 Lung Cancer Screening Software Industry Trends
8.2 Lung Cancer Screening Software Market Drivers
8.3 Lung Cancer Screening Software Market Challenges
8.4 Lung Cancer Screening Software Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Lung Cancer Screening Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Lung Cancer Screening Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Lung Cancer Screening Software Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Lung Cancer Screening Software Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Lung Cancer Screening Software Revenue Share by Region (2021-2026)
Table 6. Global Lung Cancer Screening Software Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Lung Cancer Screening Software Revenue Share Forecast by Region (2027-2032)
Table 8. Global Lung Cancer Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Lung Cancer Screening Software Market Share by Revenue, by Type (2021-2026)
Table 10. Global Lung Cancer Screening Software Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Lung Cancer Screening Software Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Lung Cancer Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Lung Cancer Screening Software Market Share by Revenue, by Application (2021-2026)
Table 15. Global Lung Cancer Screening Software Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Lung Cancer Screening Software Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Lung Cancer Screening Software Applications
Table 18. Global Lung Cancer Screening Software Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Lung Cancer Screening Software Market Share by Players (2021-2026)
Table 20. Global Top Lung Cancer Screening Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Screening Software as of 2025)
Table 21. Ranking of Global Top Lung Cancer Screening Software Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Lung Cancer Screening Software Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Lung Cancer Screening Software, Headquarters and Area Served
Table 24. Global Key Players of Lung Cancer Screening Software, Product and Application
Table 25. Global Key Players of Lung Cancer Screening Software, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Lung Cancer Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Lung Cancer Screening Software Market Share by Revenue, by Company (2021-2026)
Table 29. North America Lung Cancer Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Lung Cancer Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Lung Cancer Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Lung Cancer Screening Software Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Lung Cancer Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Lung Cancer Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 35. China Lung Cancer Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 36. China Lung Cancer Screening Software Market Share by Revenue, by Company (2021-2026)
Table 37. China Lung Cancer Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 38. China Lung Cancer Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 39. Japan Lung Cancer Screening Software Revenue by Company (2021-2026) & (US$ Million)
Table 40. Japan Lung Cancer Screening Software Market Share by Revenue, by Company (2021-2026)
Table 41. Japan Lung Cancer Screening Software Market Size by Type (2021-2026) & (US$ Million)
Table 42. Japan Lung Cancer Screening Software Market Size by Application (2021-2026) & (US$ Million)
Table 43. Siemens Healthineers Company Details
Table 44. Siemens Healthineers Business Overview
Table 45. Siemens Healthineers Lung Cancer Screening Software Product
Table 46. Siemens Healthineers Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 47. Siemens Healthineers Recent Development
Table 48. GE HealthCare Company Details
Table 49. GE HealthCare Business Overview
Table 50. GE HealthCare Lung Cancer Screening Software Product
Table 51. GE HealthCare Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 52. GE HealthCare Recent Development
Table 53. Philips Healthcare Company Details
Table 54. Philips Healthcare Business Overview
Table 55. Philips Healthcare Lung Cancer Screening Software Product
Table 56. Philips Healthcare Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 57. Philips Healthcare Recent Development
Table 58. Canon Medical Systems Company Details
Table 59. Canon Medical Systems Business Overview
Table 60. Canon Medical Systems Lung Cancer Screening Software Product
Table 61. Canon Medical Systems Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 62. Canon Medical Systems Recent Development
Table 63. United Imaging Healthcare Company Details
Table 64. United Imaging Healthcare Business Overview
Table 65. United Imaging Healthcare Lung Cancer Screening Software Product
Table 66. United Imaging Healthcare Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 67. United Imaging Healthcare Recent Development
Table 68. InferVision Company Details
Table 69. InferVision Business Overview
Table 70. InferVision Lung Cancer Screening Software Product
Table 71. InferVision Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 72. InferVision Recent Development
Table 73. Airdoc Company Details
Table 74. Airdoc Business Overview
Table 75. Airdoc Lung Cancer Screening Software Product
Table 76. Airdoc Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 77. Airdoc Recent Development
Table 78. VUNO Company Details
Table 79. VUNO Business Overview
Table 80. VUNO Lung Cancer Screening Software Product
Table 81. VUNO Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 82. VUNO Recent Development
Table 83. Lunit Company Details
Table 84. Lunit Business Overview
Table 85. Lunit Lung Cancer Screening Software Product
Table 86. Lunit Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 87. Lunit Recent Development
Table 88. Qure.ai Company Details
Table 89. Qure.ai Business Overview
Table 90. Qure.ai Lung Cancer Screening Software Product
Table 91. Qure.ai Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 92. Qure.ai Recent Development
Table 93. Riverain Technologies Company Details
Table 94. Riverain Technologies Business Overview
Table 95. Riverain Technologies Lung Cancer Screening Software Product
Table 96. Riverain Technologies Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 97. Riverain Technologies Recent Development
Table 98. Zebra Medical Vision Company Details
Table 99. Zebra Medical Vision Business Overview
Table 100. Zebra Medical Vision Lung Cancer Screening Software Product
Table 101. Zebra Medical Vision Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 102. Zebra Medical Vision Recent Development
Table 103. Arterys Company Details
Table 104. Arterys Business Overview
Table 105. Arterys Lung Cancer Screening Software Product
Table 106. Arterys Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 107. Arterys Recent Development
Table 108. Deepwise Company Details
Table 109. Deepwise Business Overview
Table 110. Deepwise Lung Cancer Screening Software Product
Table 111. Deepwise Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 112. Deepwise Recent Development
Table 113. EverFortune AI Company Details
Table 114. EverFortune AI Business Overview
Table 115. EverFortune AI Lung Cancer Screening Software Product
Table 116. EverFortune AI Revenue in Lung Cancer Screening Software Business (2021-2026) & (US$ Million)
Table 117. EverFortune AI Recent Development
Table 118. Lung Cancer Screening Software Market Trends
Table 119. Lung Cancer Screening Software Market Drivers
Table 120. Lung Cancer Screening Software Market Challenges
Table 121. Lung Cancer Screening Software Market Restraints
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Cancer Screening Software Product Picture
Figure 2. Global Lung Cancer Screening Software Market Share by Type: 2025 vs 2032
Figure 3. Cloud-Based Features
Figure 4. Web-Based Features
Figure 5. Global Lung Cancer Screening Software Market Share by Application: 2025 vs 2032
Figure 6. Hospitals
Figure 7. Medical Examination Institutions
Figure 8. Public Health Screening
Figure 9. Others
Figure 10. Lung Cancer Screening Software Report Years Considered
Figure 11. Global Lung Cancer Screening Software Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global Lung Cancer Screening Software Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Lung Cancer Screening Software Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America Lung Cancer Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe Lung Cancer Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. China Lung Cancer Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Japan Lung Cancer Screening Software Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Lung Cancer Screening Software Market Share by Players in 2025
Figure 19. Global Top Lung Cancer Screening Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Screening Software as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Lung Cancer Screening Software Revenue in 2025
Figure 21. North America Lung Cancer Screening Software Market Share by Type (2021-2026)
Figure 22. North America Lung Cancer Screening Software Market Share by Application (2021-2026)
Figure 23. Europe Lung Cancer Screening Software Market Share by Type (2021-2026)
Figure 24. Europe Lung Cancer Screening Software Market Share by Application (2021-2026)
Figure 25. China Lung Cancer Screening Software Market Share by Type (2021-2026)
Figure 26. China Lung Cancer Screening Software Market Share by Application (2021-2026)
Figure 27. Japan Lung Cancer Screening Software Market Share by Type (2021-2026)
Figure 28. Japan Lung Cancer Screening Software Market Share by Application (2021-2026)
Figure 29. Siemens Healthineers Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 30. GE HealthCare Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 31. Philips Healthcare Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 32. Canon Medical Systems Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 33. United Imaging Healthcare Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 34. InferVision Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 35. Airdoc Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 36. VUNO Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 37. Lunit Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 38. Qure.ai Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 39. Riverain Technologies Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 40. Zebra Medical Vision Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 41. Arterys Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 42. Deepwise Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 43. EverFortune AI Revenue Growth Rate in Lung Cancer Screening Software Business (2021-2026)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Lung Cancer Screening Software in 2026?
The global market size of Lung Cancer Screening Software in 2026 was 2013 Million USD.
Which region is expected to have the highest market share?
Which companies rank high in the global Lung Cancer Screening Software market?
What was the global market size of Lung Cancer Screening Software in 2032?
What is the annual compound growth rate of the global Lung Cancer Screening Software market size from 2026 to 2032?
Related Reports
Global Lung Cancer Screening Software Market Research Report 2026
The global Lung Cancer Screening Software market was valued at US$ 1706 million in 2025 and is anticipated to reach US$ 5434 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 115
USD 2900.00
(Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Lung Cancer Screening Software market is projected to grow from US$ 1706 million in 2025 to US$ 5434 million by 2032, at a CAGR of 18.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-01-14
Pages: 132
USD 4900.00
(Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Cancer Screening Software was estimated to be worth US$ 1706 million in 2025 and is projected to reach US$ 5434 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 117
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Cancer Screening Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 126
USD 4900.00
(Single User License)
Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Cancer Screening Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 77
USD 4250.00
(Single User License)
Lung Cancer Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 100
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Market Research Report 2025
The global market for Lung Cancer Screening Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 74
USD 2900.00
(Single User License)
Global Lung Cancer Screening Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Lung Cancer Screening Software Market
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)
Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-19
Pages: 92
USD 3950.00
(Single User License)
Global Lung Cancer Screening Software Market Research Report 2024
The global Lung Cancer Screening Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 79
USD 2900.00
(Single User License)
Global Lung Cancer Screening Software Market Research Report 2026
The global Lung Cancer Screening Software market was valued at US$ 1706 million in 2025 and is anticipated to reach US$ 5434 million by 2032, at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-01-14
Pages: 115
USD 2900.00 (Single User License)Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Lung Cancer Screening Software market is projected to grow from US$ 1706 million in 2025 to US$ 5434 million by 2032, at a CAGR of 18.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-01-14
Pages: 132
USD 4900.00 (Single User License)Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Cancer Screening Software was estimated to be worth US$ 1706 million in 2025 and is projected to reach US$ 5434 million, growing at a CAGR of 18.0% from 2026 to 2032.
Published: 2026-01-14
Pages: 117
USD 3950.00 (Single User License)Global Lung Cancer Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Cancer Screening Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 126
USD 4900.00 (Single User License)Global Lung Cancer Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Cancer Screening Software market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 77
USD 4250.00 (Single User License)Lung Cancer Screening Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 100
USD 3950.00 (Single User License)Global Lung Cancer Screening Software Market Research Report 2025
The global market for Lung Cancer Screening Software was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 74
USD 2900.00 (Single User License)Global Lung Cancer Screening Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Lung Cancer Screening Software Market
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)Lung Cancer Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Lung Cancer Screening Software was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-19
Pages: 92
USD 3950.00 (Single User License)Global Lung Cancer Screening Software Market Research Report 2024
The global Lung Cancer Screening Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 79
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now